US OptionsDetailed Quotes

INSM241220P70000

Watchlist

2.10
-0.10-4.55%

15min DelayClose Nov 29 13:00 ET

2.20High2.10Low

Insmed Stock Discussion

whqqq

Jun 20 02:06

8 Large Cap Stocks That Outperformed Nvidia Over The Past Year

MicroStrategy Inc.
$MicroStrategy (MSTR.US)$
— Known for its heavy investment in Bitcoin, MicroStrategy has seen significant price fluctuations but managed to outperform Nvidia’s annual performance.
Sector: Technology
Industry: Software – Application
Market Cap: $26.07B
Price: $1,469.43
1YR Perf: 400.85%
YTD Perf: 132.64%
Carvana Co.
$Carvana (CVNA.US)$
— Carvana’s innovative online car sales platform has driven strong performanc...

Golden_Peacock888

May 30 10:42

$Insmed (INSM.US)$ oh my god really no that fated，just sold it yesterday

Moomoo Recap US

May 28 15:07

Columns Tech is Hitting Highs, But the Market Was Red | Wall Street Today

The Nasdaq broke records Tuesday, jumping over 17k for the first time before pulling back following a three-day break for Memorial Day. The index hit an all-time closing high of 17,019. Still, by the numbers, about 2,000 more equities were declining than climbing.
Just after the close at 4 PM EST, the $S&P 500 Index traded up 0.03%, the $Dow Jones Industrial Average fell about 0.655%, and the $Nasdaq Composite Index closed up 0.59...

Dow tops 40,000 for the first time: Will the U.S. market rally march on?

Nice

needs more volume!!

$Insmed (INSM.US)$ look like it's stuck

Movers and Shakers

May 28 07:04

Columns Today's Morning Movers and Top Ratings: NVDA, AAPL, GME, DKNG and More

Morning Movers
Gapping up
$NVIDIA (NVDA.US)$ stock rose 2.7%, with the tech giant's stock continuing to gain, with its market value surpassing $2.5 trillion since its quarterly results, solidifying its position as the third most valuable company on Wall Street.
$Apple (AAPL.US)$ stock rose 1.9% after the iPhone maker's smartphone shipments in China were 52% higher in April than a year ago, according to data from a research firm ...

NASSER09

May 28 05:45

$Insmed (INSM.US)$ ✈️✈️✈️😊

Trytosaveabit

May 28 05:36

News

$Insmed (INSM.US)$ Insmed Says Phase 3 Study Achieves Primary Endpoint For Both Dosage Strengths Of Brensocatib With Statistically Significant, Clinically Meaningful Reduction In Frequency Of Pulmonary Exacerbations Versus Placebo
Benzinga· 2 mins ago

Meltyy

May 12 21:23

🎯 Ph 3 readouts in Q2 2024...

$United Therapeutics (UTHR.US)$ Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$ Phase 3
$Liquidia (LQDA.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$MorphoSys (MOR.US)$ Phase 3
$Immunocore (IMCR.US)$ Phase 3
$Crinetics (CRNX.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$AstraZeneca (AZN.US)$ Phase 3
$Capricor Therapeutics (CAPR.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3...

No comment yet